Myriad Genetics: Powering AI Advancements in Genetics and Precision Medicine

July 17, 2020

Myriad uses DNAnexus on AWS to perform nearly a million genetic tests each year, accelerate their R&D, and ultimately deliver better outcomes for their patients. Key highlights to be discussed are reducing experiment run times from one week to one hour, using AI for improved testing accuracy, and leveraging analytics to discover new genetic insights with vast multi-omics datasets. 

Presented by Kevin Haas, SVP of Technology, Myriad Genetics

Previous Video
Lifebit: Powering Genomics England's Research Environment & the UK's COVID-19 Research
Lifebit: Powering Genomics England's Research Environment & the UK's COVID-19 Research

Thorben Seeger, VP Commercial and Filippo Abbondanza, Bioinformatic Solution Architect, Lifebit

Next Video
Pfizer: Implementing Digital Sensor and Wearable Devices in Clinical Trials
Pfizer: Implementing Digital Sensor and Wearable Devices in Clinical Trials

Presented by Gregoire Versmee, Associate Director of Medical Informatics, Pfizer